Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Jun. 28, 2020	Jun. 30, 2019	Jun. 24, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 2,251,753,000	$ 2,191,430,000	$ 2,380,681,000
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	268,525,000	309,281,000	326,395,000
Deferred income taxes	(17,777,000)	(4,980,000)	3,046,000
Equity-based compensation expense	189,197,000	187,234,000	172,216,000
Impairment of investments	0	0
Impairment of investments			42,456,000
Amortization of note discounts and issuance costs	5,940,000	7,343,000	14,428,000
Other, net	688,000	(5,819,000)	33,718,000
Changes in operating asset and liability accounts:
Accounts receivable, net of allowance	(641,827,000)	732,138,000	(501,628,000)
Inventories	(411,608,000)	281,355,000	(701,008,000)
Prepaid expenses and other assets	(14,354,000)	(17,864,000)	(14,391,000)
Trade accounts payable	208,478,000	(131,472,000)	35,655,000
Deferred profit	76,207,000	(178,074,000)	112,413,000
Accrued expenses and other liabilities	211,229,000	(194,559,000)	751,766,000
Net cash provided by operating activities	2,126,451,000	3,176,013,000	2,655,747,000
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures and intangible assets	(203,239,000)	(303,491,000)	(273,469,000)
Business acquisition, net of cash acquired	0	0	(115,697,000)
Purchases of available-for-sale securities	(2,897,627,000)	(2,930,049,000)
Purchases of available-for-sale securities			(2,532,829,000)
Proceeds from maturities of available-for-sale securities	1,647,379,000	466,539,000	650,255,000
Proceeds from sales of available-for-sale securities	1,235,248,000	1,137,302,000
Proceeds from sales of available-for-sale securities			5,035,460,000
Other, net	(25,845,000)	(7,355,000)	(15,184,000)
Net cash (used for) provided by investing activities	(244,084,000)	(1,637,054,000)	2,748,536,000
CASH FLOWS FROM FINANCING ACTIVITIES:
Net proceeds from issuance of long-term debt	1,974,651,000	2,476,720,000	0
Principal payments on long-term debt and capital lease obligations and payments for debt issuance costs	(667,537,000)	(117,653,000)	(755,694,000)
Net (repayment) proceeds from commercial paper	0	(361,754,000)	359,604,000
Proceeds from borrowings on revolving credit facility	1,250,000,000	0	750,000,000
Repayment of borrowings on revolving credit facility	(1,250,000,000)	0	(750,000,000)
Treasury stock purchases	(1,369,649,000)	(3,780,611,000)	(2,653,249,000)
Dividends paid	(656,838,000)	(678,348,000)	(307,609,000)
Reissuances of treasury stock related to employee stock purchase plan	85,439,000	77,961,000	75,624,000
Proceeds from issuance of common stock	8,084,000	6,813,000	9,258,000
Other, net	1,920,000	(13,208,000)	9,000
Net cash used for financing activities	(623,930,000)	(2,390,080,000)	(3,272,057,000)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(2,750,000)	(4,041,000)	2,593,000
Net increase (decrease) in cash, cash equivalents and restricted cash	1,255,687,000	(855,162,000)	2,134,819,000
Cash, cash equivalents and restricted cash at beginning of year	3,913,396,000	4,768,558,000	2,633,739,000
Cash, cash equivalents and restricted cash at end of year	5,169,083,000	3,913,396,000	4,768,558,000
Schedule of non-cash transactions
Accrued payables for stock repurchases	82,000	29,000	116,000
Accrued payables for capital expenditures	37,812,000	23,185,000	24,001,000
Transfers of finished goods inventory to property and equipment, net	51,694,000	54,533,000	57,886,000
Supplemental disclosures:
Cash payments for interest	171,889,000	76,933,000	84,401,000
Cash payments for income taxes, net	222,909,000	300,268,000	142,800,000
Reconciliation of cash, cash equivalents, and restricted cash
Total cash, cash equivalents, and restricted cash	$ 3,913,396,000	$ 3,913,396,000	$ 4,768,558,000